ArticlePerspectives in clinical research
Quality of life in tuberculosis patients: A comparative study of video-observed therapy and directly observed therapy.
Article in Perspectives in clinical research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Tuberculosis (TB) is a chronic disease that negatively impacts the quality of life (QoL) due to the physical, emotional, and social challenges it poses. Digital technology has transformed the management of TB by improving patient outcomes and enabling more efficient and personalized care. One such innovation, video-observed therapy (VOT), enables healthcare workers to observe the patient taking their medication in real-time via video call. Aim: This study aims to compare the impact of VOT and directly observed therapy (DOTs) on QoL in TB patients. Methods: This observational and prospective study was conducted at a TB hospital in India, for 6 months on 110 TB patients, with 55 each in VOT group and DOTs group. Ethical approval was obtained, and patients were provided with an information sheet before signing the consent form. Demographic data were collected, and QoL was assessed using SF-36 scale. Statistical analyses were performed using SPSS software, with ANOVA and Results: Patients in the VOT group showed significantly higher QoL scores (44.10 ± 4.60, 59.36 ± 5.56) compared to the DOTs group (34.39 ± 2.88, 48.80 ± 4.05) after completing intensive and continuous phases of treatment, respectively. These improvements were notable when compared to the initiation of treatment scores (17.23 ± 4.27 for VOT and 10.82 ± 4.07 for DOTs), indicating sustained positive outcomes. Conclusion: This study provides robust evidence that integrating VOT into standard TB treatment protocols significantly enhances patients' QoL and reduces the overall disease burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.